Investigators
- Principle Investigator for Children's Oncology Group Program
- Principle Investigator for Dana-Farber Childhood Leukemia Consortium
- Treatment of childhood acute lymphoblastic leukemia (ALL) and non-Hodgkin's lymphoma
- L-Asparaginase pharmacology, pharmacodynamics and immunology treatment-related cardiac toxicity and role of cardioprotectants in preventing cardiotoxicity of cancer therapy
Lauren B. Bruckner, M.D., Ph.D.
- Infections in the immunocompromised host
- Mechanisms of acute lung injury following hematopoietic stem cell transplantation
- Clinical trials of new agents for children and adults with newly diagnosed and recurrent brain tumors
- Palliative and end-of-life care for children
- Cerebrovascular damage and neurocognitive complications in children with sickle cell disease
- Anti-platelet effects of aspirin in children
- Newborn genetics screening for the hemoglobinopathies
- Soluble CD40 Ligand and its role of pediatric coagulopathies
- The role of Notch signaling during hematopoietic and vascular differentiation of embryonic stem cells
- Identification of immunological mechanisms that can be used to design therapies to prevent the recurrence of leukemia in pediatric patients following allogeneic HCS transplant
- Cellular and molecular events underlying the initiation of hematopoiesis in the mammalian embryo
- Mechanisms regulating terminal differentiation of fetal and adult erythriod precursors
- Response of the erythroid lineage to radiation
- Chronic and terminal illness in children
- Sibling adaptation to childhood cancer
- Problem-solving skills training
- Cognitive remediation in cancer survivors
- The use of complementary medicine in allopathic practice
- Child and adolescent obesity
- Palliative and end-of-life care for children
- Red Blood Cell transcriptome and development (Erythroid progenitor cells)
- Red Blood Cell transcriptome and development (Erythroid progenitor cells)
